{"bill":{"bill_id":1657074,"change_hash":"05784dc684254cf4c30d004e086b423b","session_id":2003,"session":{"session_id":2003,"state_id":43,"year_start":2023,"year_end":2024,"prefile":0,"sine_die":0,"prior":0,"special":0,"session_tag":"Regular Session","session_title":"2023 Regular Session","session_name":"88th Legislature Regular Session"},"url":"https:\/\/legiscan.com\/TX\/bill\/SB426\/2023","state_link":"https:\/\/capitol.texas.gov\/BillLookup\/History.aspx?LegSess=88R&Bill=SB426","completed":0,"status":1,"status_date":"2023-01-12","progress":[{"date":"2023-01-12","event":1},{"date":"2023-02-15","event":9}],"state":"TX","state_id":43,"bill_number":"SB426","bill_type":"B","bill_type_id":"1","body":"S","body_id":92,"current_body":"S","current_body_id":92,"title":"Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.","description":"Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.","pending_committee_id":1911,"committee":{"committee_id":1911,"chamber":"S","chamber_id":92,"name":"Health & Human Services"},"referrals":[{"date":"2023-02-15","committee_id":1911,"chamber":"S","chamber_id":92,"name":"Health & Human Services"}],"history":[{"date":"2023-01-12","action":"Received by the Secretary of the Senate","chamber":"S","chamber_id":92,"importance":0},{"date":"2023-01-12","action":"Filed","chamber":"S","chamber_id":92,"importance":1},{"date":"2023-02-15","action":"Read first time","chamber":"S","chamber_id":92,"importance":0},{"date":"2023-02-15","action":"Referred to Health & Human Services","chamber":"S","chamber_id":92,"importance":1}],"sponsors":[{"people_id":19730,"person_hash":"dby84xc6","party_id":"2","state_id":43,"party":"R","role_id":2,"role":"Sen","name":"Angela Paxton","first_name":"Angela","middle_name":"","last_name":"Paxton","suffix":"","nickname":"","district":"SD-008","ftm_eid":44105371,"votesmart_id":177576,"opensecrets_id":"","knowwho_pid":646007,"ballotpedia":"Angela_Paxton","bioguide_id":"","sponsor_type_id":1,"sponsor_order":1,"committee_sponsor":0,"committee_id":0,"state_federal":0}],"sasts":[],"subjects":[{"subject_id":5389,"subject_name":"Health Care Providers"},{"subject_id":5273,"subject_name":"Health"},{"subject_id":5274,"subject_name":"Health--General"},{"subject_id":5554,"subject_name":"Health--Other Diseases & Medical Conditions"},{"subject_id":363089,"subject_name":"RIGHT TO TREAT ACT"},{"subject_id":340376,"subject_name":"COVID-19"},{"subject_id":5336,"subject_name":"MEDICINE & PRESCRIPTION DRUGS"},{"subject_id":5382,"subject_name":"MEDICAL BOARD, TEXAS"}],"texts":[{"doc_id":2638531,"date":"2023-01-12","type":"Introduced","type_id":1,"mime":"text\/html","mime_id":1,"url":"https:\/\/legiscan.com\/TX\/text\/SB426\/id\/2638531","state_link":"https:\/\/capitol.texas.gov\/tlodocs\/88R\/billtext\/html\/SB00426I.htm","text_size":17720,"text_hash":"a31627a5af0240bb601a1d1c33b7fb59"}],"votes":[],"amendments":[],"supplements":[],"calendar":[]}}